Background Newborn screening (NBS) for cystic fibrosis (CF) is associated with improved early nutritional outcomes and improved spirometry in children. The aim of this study was to determine whether early diagnosis and treatment of CF with NBS in New South Wales in 1981 led to better clinical outcomes and survival into early adulthood.Methods Retrospective observational study comprising two original cohorts born in the 3 years before ('non-screened cohort', n=57) and after ('screened'; n=60) the introduction of NBS. Patient records were assessed at transfer from paediatric to adult care by age 19 years and survival was documented to age 25 years.Results Non-screened patients (n=38) when compared with screened patients (n=41) had a higher ra...
Purpose of review Most treatment of newborn screening-diagnosed cystic fibrosis is not evidence-base...
Background - A study was undertaken to evaluate whether an early diagnosis by neonatal screening may...
Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9...
Background Newborn screening (NBS) for cystic fibrosis (CF) is associated with improved early nutrit...
BACKGROUND: Newborn screening for cystic fibrosis (CF) is effective in improving long-term growth ou...
OBJECTIVE. Newborn screening for cystic fibrosis remains controversial because improved pulmonary fu...
Newborn screening (NBS) for cystic fibrosis (CF) has been gradually established in several countries...
OBJECTIVES: To determine whether the improved clinical status after newborn screening (NBS) for cyst...
Importance: Newborn screening (NBS) for cystic fibrosis (CF) has been universal in the US since 2010...
Cystic fibrosis is a life-limiting condition which is readily diagnosed in the vast majority of case...
After an experimental neonatal screening program for cystic fibrosis (CF) from 1973-1979, a follow-u...
BACKGROUND: A study was undertaken to evaluate whether an early diagnosis by neonatal screening may ...
Newborn screening for cystic fibrosis has become more widespread over the last 5 years with the rece...
Background Newborn bloodspot screening (NBS) for cystic fibrosis (CF) was introduced across the UK i...
Background Newborn bloodspot screening (NBS) for cystic fibrosis (CF) was introduced across the UK i...
Purpose of review Most treatment of newborn screening-diagnosed cystic fibrosis is not evidence-base...
Background - A study was undertaken to evaluate whether an early diagnosis by neonatal screening may...
Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9...
Background Newborn screening (NBS) for cystic fibrosis (CF) is associated with improved early nutrit...
BACKGROUND: Newborn screening for cystic fibrosis (CF) is effective in improving long-term growth ou...
OBJECTIVE. Newborn screening for cystic fibrosis remains controversial because improved pulmonary fu...
Newborn screening (NBS) for cystic fibrosis (CF) has been gradually established in several countries...
OBJECTIVES: To determine whether the improved clinical status after newborn screening (NBS) for cyst...
Importance: Newborn screening (NBS) for cystic fibrosis (CF) has been universal in the US since 2010...
Cystic fibrosis is a life-limiting condition which is readily diagnosed in the vast majority of case...
After an experimental neonatal screening program for cystic fibrosis (CF) from 1973-1979, a follow-u...
BACKGROUND: A study was undertaken to evaluate whether an early diagnosis by neonatal screening may ...
Newborn screening for cystic fibrosis has become more widespread over the last 5 years with the rece...
Background Newborn bloodspot screening (NBS) for cystic fibrosis (CF) was introduced across the UK i...
Background Newborn bloodspot screening (NBS) for cystic fibrosis (CF) was introduced across the UK i...
Purpose of review Most treatment of newborn screening-diagnosed cystic fibrosis is not evidence-base...
Background - A study was undertaken to evaluate whether an early diagnosis by neonatal screening may...
Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9...